Showing 1591-1600 of 2656 results for "".
- EyeCheq adds Jai G. Parekh, MD, to its Executive Teamhttps://modernod.com/news/eyecheq-adds-jai-g-parekh-md-mba-to-its-executive-team/2481428/EyeCheq, the developer of a fully autonomous eye screening platform using artificial intelligence (AI), announced that Jai G. Parekh, MD, FAAO, has been named Executive Vice-President and Chief Innovation Officer. Dr. Parekh, a dual-train
- Three Optometric Practices in Florida Partner With US Eyehttps://modernod.com/news/us-eye-expands-into-now-5-states-50-clinics-and-5-ascs-100-providers-and-1000-team-members/2480526/Three optometric practices in Florida have partnered with US Eye. The new partnerships include Rick Billings, OD; Hart Eye Care; and Precision Eye Care of Central Florida.
- Azalea Vision Raises €9 Million to Further Develop Intelligent Connected Vision Platformhttps://modernod.com/news/azalea-vision-raises-eur9-million-to-further-develop-intelligent-connected-vision-platform/2482765/Startup biotech company Azalea Vision announced the first closing of its €15 million Series A funding round, raising €9 million. In addition, the company announced that Robert J. Dempsey has been appointed Chairman of the Board to guide strategic growth in the European an
- Lighthouse Guild Appoints Thomas Panek as New President and CEOhttps://modernod.com/news/lighthouse-guild-appoints-thomas-panek-as-new-president-and-ceo/2482706/Lighthouse Guild announced this morning that Thomas Panek has been appointed as President and CEO, effective April 2025. He succeeds Dr. Calvin W. Roberts, who has served in this role for the past 5 years. Mr. Panek has significant leadership experience with a deep commitment to a
- First Patients Treated with Lensar's ALLY Adaptive Cataract Treatment Systemhttps://modernod.com/news/first-patients-treated-with-lensars-ally-adaptive-cataract-treatment-system/2481029/Lensar announced the first commercial cases performed with the ALLY Adaptive Cataract Treatment System by Robert Weinstock, MD, at The Eye Institute of West Florida. Dr. Weinstock performed 15 laser-assisted cataract surgery cases following the recent installation of his ALLY Syste
- TearClear Raises $22M in Series B Fundinghttps://modernod.com/news/tearclear-raises-22m-in-series-b-funding/2478158/TearClear announced it has raised $22 million in a Series B funding round. The company intends to use the funds to advance multiple clinical programs in development, with two lead candidates in glaucoma paving the way for future indications. Led by Chief Executive Officer Robert Dempsey, T
- Tangible Science Announces CEO Transitionhttps://modernod.com/news/tangible-science-announces-ceo-transition/2482613/Tangible Science, a provider of specialty contact lens technology, announced that Karen Havenstrite, PhD, MBA, co-founder and former Chief Technology Officer, has been appointed Chief Executive Officer. Dr. Havenstrite suceeds Victor McCray, MD, who will transition to the
- Abigail Markward Named Executive Director of ASOAhttps://modernod.com/news/abigail-markward-named-executive-director-of-asoa/2482399/The American Society of Ophthalmic Administrators (ASOA) has announced the appointment of Abigail Markward, MBA, as its new executive director, effective immediately. In addition to this new role, Ms. Markward will continue her responsibilities as executive director of the ASCRS Foundation, a pos
- Amring Pharmaceuticals Names Jai G. Parekh, MD, Chief Commercial Officer, Eye Care, UShttps://modernod.com/news/amring-pharmaceuticals-names-jai-g-parekh-md-chief-commercial-officer-eye-care-us/2482059/Amring Pharmaceuticals, a subsidiary of Nordic Group BV, has named Jai G. Parekh, MD, MBA, as Chief Commercial Officer, Eye Care, US. Nordic Pharma recently expanded its pharmaceutical presence in the US by acquiring Visant Medical, maker of the FDA-c
- Ocuphire Pharma Names Joseph Schachle as COOhttps://modernod.com/news/ocuphire-pharma-names-joseph-schachle-as-coo/2481981/Ocuphire Pharma announced the appointment of Joseph (Joe) K. Schachle, MBA, into the newly created role of Chief Operating Officer, effective immediately. Ocuphire is a clinical-stage company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refra